ETF Managers Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$311K	Sell	723,151 -787,721	-52%	-$415K	0.01%	531
2022 Q4	$801K	Sell	1,510,872 -748,098	-33%	-$474K	0.04%	189
2022 Q3	$1.65M	Sell	2,258,970 -188,437	-8%	-$214K	0.05%	165
2022 Q2	$2.81M	Sell	2,447,407 -1,214,935	-33%	-$1.55M	0.08%	145
2022 Q1	$7.87M	Sell	3,662,342 -923,399	-20%	-$2.2M	0.16%	124
2021 Q4	$13.3M	Buy	4,585,741 +121,967	+3%	+$451K	0.26%	110
2021 Q3	$18.7M	Sell	4,463,774 -115,506	-3%	-$515K	0.35%	89
2021 Q2	$24.8M	Buy	4,579,280 +2,591,494	+130%	+$12.5M	0.4%	86
2021 Q1	$9.24M	Buy	1,987,786 +173,458	+10%	+$786K	0.16%	126
2020 Q4	$5.99M	Buy	1,814,328 +923,303	+104%	+$3.51M	0.13%	120
2020 Q3	$2.95M	Sell	891,025 -350,571	-28%	-$1.29M	0.09%	136
2020 Q2	$4.18M	Buy	1,241,596 +33,470	+3%	+$158K	0.15%	109
2020 Q1	$4.63M	Sell	1,208,126 -828,404	-41%	-$3.85M	0.21%	94
2019 Q4	$12.3M	Sell	2,036,530 -642,927	-24%	-$4.4M	0.43%	83
2019 Q3	$20.3M	Buy	2,679,457 +441,614	+20%	+$4.98M	0.73%	45
2019 Q2	$30.3M	Buy	+2,237,843	New	+$25.8M	0.97%	40